LOINC_NUM
stringlengths 3
8
| COMPONENT
stringlengths 2
246
| PROPERTY
stringlengths 1
29
| TIME_ASPCT
stringlengths 1
15
| SYSTEM
stringlengths 1
106
| SCALE_TYP
stringclasses 10
values | METHOD_TYP
stringlengths 1
57
⌀ | CLASS
stringlengths 2
24
| CLASSTYPE
int64 1
4
| LONG_COMMON_NAME
stringlengths 3
254
| SHORTNAME
stringlengths 2
51
⌀ | EXTERNAL_COPYRIGHT_NOTICE
stringlengths 39
2.6k
⌀ | STATUS
stringclasses 4
values | VersionFirstReleased
stringlengths 1
7
| VersionLastChanged
stringlengths 1
5
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
93155-0 | IRF-PAI v4.0, LCDS v5.00, OASIS E - High risk drug classes - use and indication | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | IRF-PAI v4.0, LCDS v5.00, OASIS E - High risk drug classes - use and indication [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.72 |
93156-8 | How much of the time has pain made it hard for you to sleep at night over the past 5D | Find | 5D | ^Patient | Ord | CMS Assessment | SURVEY.CMS | 4 | How much of the time has pain made it hard for you to sleep at night over the past 5 days [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.67 |
93157-6 | How often do you need to have someone help you when you read instructions, pamphlets, or other written material from your doctor or pharmacy | Find | Pt | ^Patient | Ord | SILS | SURVEY.CMS | 4 | How often do you need to have someone help you when you read instructions, pamphlets, or other written material from your doctor or pharmacy [SILS] | null | © 2006 Morris et al. Used with permission | ACTIVE | 2.67 | 2.67 |
93158-4 | How often have you limited your day-to-day activities because of pain over the past 5D | Find | 5D | ^Patient | Ord | CMS Assessment | SURVEY.CMS | 4 | How often have you limited your day-to-day activities because of pain over the past 5 days [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.67 |
93159-2 | How often do you feel lonely or isolated from those around you | Find | Pt | ^Patient | Ord | CMS Assessment | SURVEY.CMS | 4 | How often do you feel lonely or isolated from those around you [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.67 |
931-6 | Blood product source | Type | Pt | ^BPU | Nom | null | BLDBK | 1 | Blood product source [Type] | Bld Prod Source BPU | null | ACTIVE | 1.0 | 2.73 |
93160-0 | How often have you limited your participation in rehabilitation therapy sessions due to pain over the past 5D | Find | 5D | ^Patient | Ord | CMS Assessment | SURVEY.CMS | 4 | How often have you limited your participation in rehabilitation therapy sessions due to pain over the past 5 days [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.67 |
9316-1 | Western equine encephalitis virus Ab.IgM | Titr | Pt | CSF | Qn | IF | MICRO | 1 | Western equine encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | WEEV IgM Titr CSF IF | null | ACTIVE | 1.0i | 2.73 |
93161-8 | IRF-PAI v4.0 - Administrative information | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | IRF-PAI v4.0 - Administrative information [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.67 |
93162-6 | IRF-PAI v4.0 - Cognitive patterns - admission | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | IRF-PAI v4.0 - Cognitive patterns - admission [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.68 |
93163-4 | IRF-PAI v4.0 - Cognitive patterns - discharge | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | IRF-PAI v4.0 - Cognitive patterns - discharge [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.68 |
93164-2 | IRF-PAI v4.0 - Health conditions - admission | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | IRF-PAI v4.0 - Health conditions - admission [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.67 |
93165-9 | IRF-PAI v4.0 - Hearing, speech, and vision - admission | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | IRF-PAI v4.0 - Hearing, speech, and vision - admission [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.67 |
93166-7 | IRF-PAI v4.0, OASIS E - Hearing, speech, and vision - ROC, DC | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | IRF-PAI v4.0, OASIS E - Hearing, speech, and vision - ROC, DC [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.72 |
93167-5 | IRF-PAI v4.0 - Identification information | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | IRF-PAI v4.0 - Identification information [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.73 |
93168-3 | IRF-PAI v4.0, LCDS v5.00 - Medications - admission | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | IRF-PAI v4.0, LCDS v5.00 - Medications - admission [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.67 |
93169-1 | IRF-PAI v4.0, LCDS v5.00 - Medications - discharge | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | IRF-PAI v4.0, LCDS v5.00 - Medications - discharge and expired [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.67 |
93170-9 | IRF-PAI v4.0, LCDS v5.00, OASIS E - Mood | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | IRF-PAI v4.0, LCDS v5.00, OASIS E - Mood [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.72 |
93171-7 | IRF-PAI v4.0 - Quality indicators - admission | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | IRF-PAI v4.0 - Quality indicators - admission [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.68 |
93172-5 | IRF-PAI v4.0 - Quality indicators - discharge | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | IRF-PAI v4.0 - Quality indicators - discharge [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.68 |
93173-3 | IRF-PAI v4.0 - Special treatments, procedures, and programs - admission | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | IRF-PAI v4.0 - Special treatments, procedures, and programs - admission [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.67 |
93174-1 | IRF-PAI v4.0 - Special treatments, procedures, and programs - discharge | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | IRF-PAI v4.0 - Special treatments, procedures, and programs - discharge [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.67 |
93175-8 | IRF-PAI v4.0 - Swallowing &or nutritional status - admission | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | IRF-PAI v4.0 - Swallowing/nutritional status - admission [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.67 |
93176-6 | IRF-PAI v4.0, LCDS v5.00 - Swallowing &or nutritional status - discharge | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | IRF-PAI v4.0, LCDS v5.00 - Swallowing/nutritional status - discharge [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.68 |
93177-4 | IRF-PAI v4.0, LCDS v5.00 - Health conditions - discharge or expired | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | IRF-PAI v4.0, LCDS v5.00 - Health conditions - discharge or expired [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.69 |
93178-2 | Nutritional approaches | Find | Pt | ^Patient | Nom | CMS Assessment | SURVEY.CMS | 4 | Nutritional approaches [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.67 |
9317-9 | Platelets | PrThr | Pt | Bld | Ord | Microscopy.light | HEM/BC | 1 | Platelet adequacy [Presence] in Blood by Light microscopy | Platelet Bld Ql Smear | null | ACTIVE | 1.0i | 2.73 |
93180-8 | IRF-PAI v4.0, LCDS v5.00 - Nutritional approaches - last 7D and discharge | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | IRF-PAI v4.0, LCDS v5.00 - Nutritional approaches - last 7D and discharge [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.69 |
93181-6 | Provision of current reconciled medication list to patient at discharge | Find | Pt | ^Patient | Ord | CMS Assessment | SURVEY.CMS | 4 | Provision of current reconciled medication list to patient at discharge [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.67 |
93182-4 | Provision of current reconciled medication list to subsequent provider at discharge | Find | Pt | ^Patient | Ord | CMS Assessment | SURVEY.CMS | 4 | Provision of current reconciled medication list to subsequent provider at discharge [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.67 |
93183-2 | Route of current reconciled medication list transmission to patient | Find | Pt | ^Patient | Nom | CMS Assessment | SURVEY.CMS | 4 | Route of current reconciled medication list transmission to patient [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.67 |
93184-0 | Route of current reconciled medication list transmission to subsequent provider | Find | Pt | ^Patient | Nom | CMS Assessment | SURVEY.CMS | 4 | Route of current reconciled medication list transmission to subsequent provider [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.67 |
93185-7 | Special treatments, procedures, and programs at discharge | Find | RptPeriod | ^Patient | Nom | CMS Assessment | SURVEY.CMS | 4 | Special treatments, procedures, and programs at discharge [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.69 |
93186-5 | Preferred language & interpreter need | - | Pt | ^Patient | - | null | PANEL.ADMIN | 2 | Preferred language and interpreter need | Preferred lang + interp need | null | ACTIVE | 2.67 | 2.72 |
9318-7 | Albumin/Creatinine | MRto | Pt | Urine | Qn | null | CHEM | 1 | Albumin/Creatinine [Mass Ratio] in Urine | Albumin/Creat Ur | null | ACTIVE | 1.0i | 2.73 |
93187-3 | Bone age assessment - Tanner-Whitehouse (TW2) associated observations panel | - | Pt | ^Patient | - | null | PANEL.RAD | 2 | Bone age assessment - Tanner-Whitehouse (TW2) associated observations panel | Bone age assess TW2 panel | null | ACTIVE | 2.67 | 2.67 |
93188-1 | IRF-PAI v4.0 - Administrative information - discharge | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | IRF-PAI v4.0 - Administrative information - discharge [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.67 |
93189-9 | Total skeletal maturity score | Score | Pt | Upper extremity>Wrist+Hand | Qn | XR | RAD | 2 | XR Wrist and Hand Total skeletal maturity score | XR Wrist+Hand Total maturity score | null | ACTIVE | 2.67 | 2.67 |
93190-7 | HTR2A gene.c.614-2211T>C | Geno | Pt | Bld/Tiss | Nom | Molgen | MOLPATH.PHARMG | 1 | HTR2A gene c.614-2211T>C [Genotype] in Blood or Tissue by Molecular genetics method Nominal | HTR2A c.614-2211T>C Geno Bld/T | null | ACTIVE | 2.67 | 2.68 |
93191-5 | HTR2C gene.c.-759C>T | Geno | Pt | Bld/Tiss | Nom | Molgen | MOLPATH.PHARMG | 1 | HTR2C gene c.-759C>T [Genotype] in Blood or Tissue by Molecular genetics method Nominal | HTR2C c.-759C>T Geno Bld/T | null | ACTIVE | 2.67 | 2.68 |
93192-3 | HTR2C gene.c.551-3008C>G | Geno | Pt | Bld/Tiss | Nom | Molgen | MOLPATH.PHARMG | 1 | HTR2C gene c.551-3008C>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal | HTR2C c.551-3008C>G Geno Bld/T | null | ACTIVE | 2.67 | 2.68 |
93193-1 | TPMT gene & NUDT15 gene targeted mutation analysis | Find | Pt | Bld/Tiss | Doc | Molgen | MOLPATH.PHARMG | 1 | TPMT gene and NUDT15 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | TPMT + NUDT15 Mut Anl Bld/T | null | ACTIVE | 2.67 | 2.67 |
93194-9 | NUDT15 gene targeted mutation analysis | Prid | Pt | Bld/Tiss | Nom | Molgen | MOLPATH.PHARMG | 1 | NUDT15 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | NUDT15 gene Mut Anl Bld/T | null | ACTIVE | 2.67 | 2.67 |
9319-5 | Androstenedione | MRat | 24H | Urine | Qn | null | CHEM | 1 | Deprecated Androstenedione [Mass/time] in 24 hour Urine | Deprecated Androst 24H Ur-mRate | null | DEPRECATED | 1.0i | 2.36 |
93195-6 | NUDT15 gene product metabolic activity interpretation | Imp | Pt | Bld/Tiss | Ord | Molgen | MOLPATH.PHARMG | 1 | NUDT15 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method | NUDT15 gene prod met act imp Bld/T-Imp | null | ACTIVE | 2.67 | 2.68 |
93196-4 | Warfarin response genotype panel | - | Pt | Bld/Tiss | - | Molgen | PANEL.MOLPATH.PHARMG | 1 | Warfarin response genotype panel - Blood or Tissue by Molecular genetics method | Warfarin genotype pnl Bld/T | null | ACTIVE | 2.67 | 2.67 |
93197-2 | CYP4F2 gene.c.1297G>A | Geno | Pt | Bld/Tiss | Nom | Molgen | MOLPATH.PHARMG | 1 | CYP4F2 gene c.1297G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal | CYP4F2 c.1297G>A Geno Bld/T | null | ACTIVE | 2.67 | 2.68 |
93198-0 | 10q23 g.94645745G>A | Geno | Pt | Bld/Tiss | Nom | Molgen | MOLPATH.PHARMG | 1 | 10q23 g.94645745G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal | 10q23 g.94645745G>A Geno Bld/T | null | ACTIVE | 2.67 | 2.68 |
93199-8 | DPYD gene targeted mutation analysis | Find | Pt | Bld/Tiss | Doc | Molgen | MOLPATH.PHARMG | 1 | DPYD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | DPYD gene Mut Anl Bld/T | null | ACTIVE | 2.67 | 2.67 |
93200-4 | Ehlers-Danlos syndrome multigene analysis | Find | Pt | Bld/Tiss | Doc | Molgen | MOLPATH | 1 | Ehlers-Danlos syndrome multigene analysis in Blood or Tissue by Molecular genetics method | EDS Multigene Anl Bld/T | null | ACTIVE | 2.67 | 2.67 |
93201-2 | Coronary heart disease multigene analysis | Find | Pt | Bld/Tiss | Doc | Molgen | MOLPATH | 1 | Coronary heart disease multigene analysis in Blood or Tissue by Molecular genetics method | CHD Multigene Anl Bld/T | null | ACTIVE | 2.67 | 2.67 |
93202-0 | Ventilator weaning status | Find | Pt | ^Patient | Ord | CMS Assessment | SURVEY.CMS | 4 | Ventilator weaning status [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.67 |
9320-3 | Beta aminoisobutyrate | MRat | 24H | Urine | Qn | null | CHEM | 1 | Beta aminoisobutyrate [Mass/time] in 24 hour Urine | B-AIB 24h Ur-mRate | null | DISCOURAGED | 1.0i | 2.44 |
93203-8 | LCDS v5.00 - Spontaneous breathing trial | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | LCDS v5.00 - Spontaneous breathing trial [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.67 |
93204-6 | LCDS v5.00 - Special treatments, procedures, and programs - discharge | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | LCDS v5.00 - Special treatments, procedures, and programs - discharge [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.67 |
93205-3 | LCDS v5.00 - Special treatments, procedures, and programs - admission | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | LCDS v5.00 - Special treatments, procedures, and programs - admission [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.67 |
93207-9 | LCDS v5.00 - Swallowing &or nutritional status - admission | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | LCDS v5.00 - Swallowing/nutritional status - admission [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.67 |
93208-7 | LCDS v5.00 - Health conditions - admission | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | LCDS v5.00 - Health conditions - admission [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.67 |
93209-5 | LCDS v5.00 - Functional abilities and goals - planned discharge | - | RptPeriod | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | LCDS v5.00 - Functional abilities and goals - planned discharge [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.69 |
93210-3 | LCDS v5.00 - Functional abilities and goals - admission | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | LCDS v5.00 - Functional abilities and goals - admission [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.67 |
9321-1 | Calcium/Creatinine | MRto | Pt | Urine | Qn | null | CHEM | 1 | Calcium/Creatinine [Mass Ratio] in Urine | Calcium/Creat Ur | null | ACTIVE | 1.0i | 2.73 |
93211-1 | LCDS v5.00 - Cognitive patterns - unplanned discharge | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | LCDS v5.00 - Cognitive patterns - unplanned discharge [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.68 |
93212-9 | LCDS v5.00 - Cognitive patterns - planned discharge | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | Deprecated LCDS v5.00 - Cognitive patterns - planned discharge [CMS Assessment] | null | null | DEPRECATED | 2.67 | 2.7 |
93213-7 | LCDS v5.00 - Cognitive patterns - admission and planned discharge | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | LCDS v5.00 - Cognitive patterns - admission and planned discharge [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.69 |
93214-5 | LCDS v5.00 - Hearing, speech, and vision - discharge | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | LCDS v5.00 - Hearing, speech, and vision - discharge [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.67 |
93215-2 | LCDS v5.00 - Hearing, speech, and vision - admission | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | LCDS v5.00 - Hearing, speech, and vision - admission [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.67 |
93216-0 | LCDS v5.00 - Administrative information - expired | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | LCDS v5.00 - Administrative information - expired [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.67 |
93217-8 | LCDS v5.00 - Administrative information - planned discharge | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | LCDS v5.00 - Administrative information - planned discharge [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.67 |
93218-6 | LCDS v5.00 - Administrative information - admission | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | LCDS v5.00 - Administrative information - admission [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.67 |
93219-4 | Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Expired - version 5.00 | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Expired - version 5.00 [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.68 |
93220-2 | Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Unplanned Discharge - version 5.00 | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Unplanned Discharge - version 5.00 [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.68 |
93221-0 | Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Planned Discharge - version 5.00 | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Planned Discharge - version 5.00 [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.68 |
93222-8 | Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Admission - version 5.00 | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Admission - version 5.00 [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.68 |
93223-6 | Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - version 5.00 | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - version 5.00 [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.68 |
93224-4 | Coccidioides sp Ag | MCnc | Pt | BAL | Qn | IA | MICRO | 1 | Coccidioides sp Ag [Mass/volume] in Bronchoalveolar lavage by Immunoassay | Coccidioides Ag BAL IA-mCnc | null | ACTIVE | 2.67 | 2.67 |
93225-1 | Coccidioides sp Ag | MCnc | Pt | CSF | Qn | IA | MICRO | 1 | Coccidioides sp Ag [Mass/volume] in Cerebral spinal fluid by Immunoassay | Coccidioides Ag CSF IA-mCnc | null | ACTIVE | 2.67 | 2.67 |
93226-9 | Coccidioides sp Ag | MCnc | Pt | Ser/Plas | Qn | IA | MICRO | 1 | Coccidioides sp Ag [Mass/volume] in Serum or Plasma by Immunoassay | Coccidioides Ag SerPl IA-mCnc | null | ACTIVE | 2.67 | 2.67 |
93227-7 | Coccidioides sp Ag | MCnc | Pt | Urine | Qn | IA | MICRO | 1 | Coccidioides sp Ag [Mass/volume] in Urine by Immunoassay | Coccidioides Ag Ur IA-mCnc | null | ACTIVE | 2.67 | 2.67 |
93228-5 | LCDS v5.00 - Patient demographic information - unplanned discharge and expired | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | LCDS v5.00 - Patient demographic information - unplanned discharge and expired [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.67 |
9322-9 | Cholesterol.total/Cholesterol.in HDL | Prctl | Pt | Ser/Plas | Qn | null | CHEM | 1 | Cholesterol.total/Cholesterol in HDL [Percentile] | Cholest/HDLc Prctl SerPl | null | ACTIVE | 1.0i | 2.73 |
93229-3 | LCDS v5.00 - Patient demographic information - admission | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | LCDS v5.00 - Patient demographic information - admission [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.67 |
93230-1 | LCDS v5.00 - Patient demographic information - planned discharge | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | LCDS v5.00 - Patient demographic information - planned discharge [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.67 |
93231-9 | LCDS v5.00 - Administrative information - unplanned discharge | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | LCDS v5.00 - Administrative information - unplanned discharge [CMS Assessment] | null | null | ACTIVE | 2.67 | 2.67 |
93232-7 | Imipenem+Relebactam | Susc | Pt | Isolate | OrdQn | Gradient strip | ABXBACT | 1 | Imipenem+Relebactam [Susceptibility] by Gradient strip | Imi+Rel Islt Grad strip | null | ACTIVE | 2.67 | 2.67 |
93233-5 | Intercellular substance Ab.IgG | PrThr | Pt | Ser | Ord | IF | SERO | 1 | Intercellular substance IgG Ab [Presence] in Serum by Immunofluorescence | ICS IgG Ser Ql IF | null | ACTIVE | 2.67 | 2.67 |
93234-3 | Coagulation dilute Russell viper venom induced^post heparin neutralization | Time | Pt | PPP | Qn | Coag | COAG | 1 | dRVVT in Platelet poor plasma by Coagulation assay --post heparin neutralization | dRVVT p hep neut PPP | null | ACTIVE | 2.67 | 2.67 |
93235-0 | Coagulation surface induced.lupus sensitive^post heparin neutralization | Time | Pt | PPP | Qn | Coag | COAG | 1 | aPTT.lupus sensitive in Platelet poor plasma by Coagulation assay --post heparin neutralization | aPTT-LA p hep neut PPP | null | ACTIVE | 2.67 | 2.67 |
93236-8 | Coagulation surface induced.lupus sensitive.excess phospholipid^post heparin neutralization | Time | Pt | PPP | Qn | Coag | COAG | 1 | aPTT.lupus sensitive.excess phospholipid in Platelet poor plasma by Coagulation assay --post heparin neutralization | aPTT-LA confirm p hep neut PPP | null | ACTIVE | 2.67 | 2.67 |
9323-7 | Sarcosine | SCnc | 24H | Urine | Qn | null | CHEM | 1 | Sarcosine [Moles/volume] in 24 hour Urine | Sarcosine 24h Ur-sCnc | null | ACTIVE | 1.0i | 2.73 |
93237-6 | Coagulation surface induced.lupus sensitive.excess phospholipid actual/Normal^post heparin neutralization | RelTime | Pt | PPP | Qn | Coag | COAG | 1 | aPTT.lupus sensitive.excess phospholipid actual/normal in Platelet poor plasma by Coagulation assay --post heparin neutralization | aPTT-LA confirm Act/Nor p hep neut PPP | null | ACTIVE | 2.67 | 2.67 |
93238-4 | Coagulation dilute Russell viper venom induced.excess phospholipid^post heparin neutralization | Time | Pt | PPP | Qn | Coag | COAG | 1 | dRVVT excess phospholipid in Platelet poor plasma by Coagulation assay --post heparin neutralization | dRVVT confirm p hep neut PPP | null | ACTIVE | 2.67 | 2.67 |
93239-2 | Coagulation dilute Russell viper venom induced.excess phospholipid actual/normal^post heparin neutralization | RelTime | Pt | PPP | Qn | Coag | COAG | 1 | dRVVT excess phospholipid actual/normal in Platelet poor plasma by Coagulation assay --post heparin neutralization | dRVVT confirm Act/Nor p hep neut PPP | null | ACTIVE | 2.67 | 2.67 |
932-4 | Blood product type | Type | Pt | BBL | Nom | null | BLDBK | 1 | Deprecated Blood product type | Deprecated Bld Prod Typ BBL | null | DEPRECATED | 1.0 | 2.36 |
93240-0 | Coagulation dilute Russell viper venom induced.factor substitution^immediately after 1:1 addition of normal plasma+heparin neutralization | Time | Pt | PPP | Qn | Coag | COAG | 1 | dRVVT factor substitution in Platelet poor plasma by Coagulation assay --immediately after 1:1 addition of normal plasma and heparin neutralization | dRVVT imm 1:1 NP+hep neut PPP | null | ACTIVE | 2.67 | 2.67 |
93241-8 | Multisection | Find | Pt | XXX | Doc | US.doppler | RAD | 2 | US.doppler Unspecified body region | DOP Unsp region | null | ACTIVE | 2.67 | 2.67 |
93242-6 | 11-Ketotestosterone | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | 11-Ketotestosterone [Mass/volume] in Serum or Plasma | 11Ketotestost SerPl-mCnc | null | ACTIVE | 2.67 | 2.67 |
93243-4 | 11-Hydroxytestosterone | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | 11-Hydroxytestosterone [Mass/volume] in Serum or Plasma | 11OH-Testost SerPl-mCnc | null | ACTIVE | 2.67 | 2.67 |
93244-2 | Complement Sc5b-9 | MCnc | Pt | Ser/Plas | Qn | IA | SERO | 1 | Complement Sc5b-9 [Mass/volume] in Serum or Plasma by Immunoassay | SC5b9 SerPl IA-mCnc | null | ACTIVE | 2.67 | 2.67 |
9324-5 | Taurine | SCnc | 24H | Urine | Qn | null | CHEM | 1 | Taurine [Moles/volume] in 24 hour Urine | Taurine 24h Ur-sCnc | null | ACTIVE | 1.0i | 2.73 |
93245-9 | Columbia - suicide severity rating scale - lifetime recent | - | Pt | ^Patient | - | C-SSRS | PANEL.SURVEY.CSSRS | 4 | Columbia - suicide severity rating scale - lifetime recent [C-SSRS] | null | © 2008 Research Foundation of Mental Hygiene, Inc. Used with permission | ACTIVE | 2.67 | 2.68 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.